Reduction in Baseline CD4 Count Testing following Human Immunodeficiency Virus "treat All" Adoption in Uganda

Esther Nasuuna, Mark W. Tenforde, Alex Muganzi, Joseph N. Jarvis, Yukari C. Manabe, Joanita Kigozi

Research output: Contribution to journalArticlepeer-review

Abstract

Baseline CD4 testing rates declined from 73% to 21% between 2013 and 2018 with adoption of "Treat All"in Uganda. Advanced human immunodeficiency virus (HIV) disease (CD4 count < 200 cells/μL) remained common (24% of those tested in 2018, 83% of whom had World Health Organization stage I/II disease). Despite frequent presentation with advanced HIV disease, CD4 testing has declined dramatically.

Original languageEnglish (US)
Pages (from-to)2497-2499
Number of pages3
JournalClinical Infectious Diseases
Volume71
Issue number9
DOIs
StatePublished - Nov 1 2020

Keywords

  • CD4
  • HIV
  • opportunistic infections
  • test-and-treat
  • treat all

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Reduction in Baseline CD4 Count Testing following Human Immunodeficiency Virus "treat All" Adoption in Uganda'. Together they form a unique fingerprint.

Cite this